Skip to main content

Month: June 2021

Novartis investigational oral therapy iptacopan (LNP023) shows benefit as monotherapy in treatment-naïve patients with rare and life-threatening blood disorder paroxysmal nocturnal hemoglobinuria

First-in-class, oral, targeted factor B inhibitor iptacopan substantially reduced both intra- and extravascular hemolysis when given as monotherapy in a Phase II study of anti-C5 naïve paroxysmal nocturnal hemoglobinuria (PNH) patients1New results are promising for potential use of iptacopan as monotherapy in PNH, a rare and life-threatening blood disorder2,3; results from a previous Phase II study showed iptacopan substantially improved hematological response as add-on to standard-of-care (eculizumab)4The FDA has granted Breakthrough Therapy Designation to iptacopan for PNH5; it also has received orphan drug designation for PNH from both the FDA and EMA6Iptacopan is also in development for several rare renal conditions with complement system (part of the innate immune system) involvement, targeting a key driver of these diseases7,8Recently...

Continue reading

Celyad Oncology Presents Preliminary Data from Phase 1 IMMUNICY-1 Trial of shRNA-based Allogeneic CAR T Candidate CYAD-211 in Relapsed/Refractory Multiple Myeloma at the European Hematology Association Virtual Congress

Treatment with CYAD-211 generally well-tolerated at first two dose levels, with no evidence of Graft-versus-Host Disease observed Two partial responses observed among five evaluable patients Cell engraftment of CYAD-211 observed in all patients from dose level 2, with evidence of CAR T cells in all patients enrolled in first two dose cohorts Additional clinical data from the dose escalation trial are expected during second half 2021 Management to host conference call later today, June 11, at 2 p.m. CET / 8 a.m. ETMONT-SAINT-GUIBERT, Belgium, June 11, 2021 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced preliminary data from the Phase 1 IMMUNICY-1...

Continue reading

Trading in Sdiptech’s shares commences today on Nasdaq Stockholm

Press release 11 June 2021, 08:35 Trading in Sdiptech’s shares commences today on Nasdaq Stockholm Sdiptech AB (publ) announces that trading in the company’s ordinary shares of series B and preference shares (the “Shares”) will today begin on Nasdaq Stockholm’s main market. “Since the IPO in 2017, Sdiptech has almost doubled the number of employees, been properly established outside the Nordic region and had an average annual profit growth of 36 percent. I’m extra pleased about the fact that we are now classified as a Large Cap company, which is another proof of the great growth journey that Sdiptech has had in recent years. The shift to Nasdaq Stockholm is a hallmark of quality, a milestone on the road and another building block in our strategy for continued international growth”, says Jakob Holm, CEO of Sdiptech. The Shares...

Continue reading

Interoil announces changes in financial calendar

Oslo, 11 June 2021 – Interoil Exploration and Production ASA (Interoil) regrets to inform about further delays in the preparation of the company’s annual report for 2020. The annual general meeting, and the report for the first quarter 2021 will also be postponed. The new dates are as follows. Annual Report 2020 – 25 June 2021Q1 Interim Financial Report – 16 July 2021Annual General Meeting – 28 July 2021 *************************** Interoil Exploration and Production ASA is a Norwegian based exploration and production company – listed on the Oslo Stock Exchange – with focus on Latin America. The Company is operator and license holder of several production and exploration assets in Colombia and Argentina. Interoil currently employs approximately 50 people and is headquartered in Oslo. This information is subject to the disclosure...

Continue reading

DFDS: MAY VOLUME REPORT: FREIGHT UP 31% FOLLOWING LOCKDOWNS IN 2020

INVESTOR NEWS NO. 22/2021   DFDS reports monthly ferry volumes for freight and passengers to provide additional insight into the development of volume trends in DFDS’ European route network.DFDS ferry volumes              May   LTM*Freight 2020 2021 Change   2019-20 2020-21 ChangeLane metres, ‘000 2,782 3,650 31.2%   39,540 43,125 9.1%               Passenger 2020 2021 Change   2019-20 2020-21 ChangePassengers, ‘000 48 35 -27.3%   4,122 989 -76.0%*Last twelve months              Ferry – freight: Total volumes in May 2021 were 31.2% above 2020. Net adjustments for structural route changes reduced growth 3.2 ppt to 28.0%. The extraordinary volume growth in May 2021 vs 2020 reflected a recovery from the significant volume reductions in May 2020 caused by Covid-19 related lockdowns. Volumes in...

Continue reading

Crowdfunding solves the problem of finding investments

If you have an idea for a new product or service, but implementing a business project requires funds: temporary, monetary, or expert, you need a Fuji investor. Humanity has long thought about how to help startups with the search for investors. One of these ways, made possible by the development of the Internet – is crowdfunding. To get investments or coins, you need to register your project on a Fuji crowdfunding platform. As a rule, you will get many investors and the main return for them will be rather not material benefits, but the very idea of ​​participating in creating a new project. Of course, investors can offer you their investments in exchange for a share in your business, or further material rewards after your business generates income. This is the fundamental difference between crowdfunding and other types of financing. The...

Continue reading

Amundi and Société Générale: Signature of the master agreement for the acquisition of Lyxor by Amundi – Finalisation expected at end-2021

Press release Paris, 11 June 2021 Signature of the master agreement for the acquisition of Lyxor by AmundiFinalisation expected at end-2021 Amundi and Société Générale announce the signature, earlier than the considered schedule, of the master agreement for Amundi’s acquisition of Lyxor1; as a reminder, the entry into exclusive negotiations had been announced on 7 April2. The finalisation of this transaction is expected at the end of 20213, subject to the prior approval of the competent regulatory and competition authorities. *** About Amundi Amundi, the leading European asset manager, ranking among the top 10 global players4, offers its 100 million clients – retail investors, institutional investors and companies – a complete range of savings and investment solutions in active and passive management, in traditional or real assets....

Continue reading

Learning Management System (LMS) Market: Absorb Software Acquires ePath Learning to Broaden its Presence in Industry

Key companies covered in the Learning Management System (LMS) Market Research report include McGraw Hill. (New York, United States), D2L Corporation. (Kitchener, Canada), SAP SE (Walldorf, Germany), Saba Software (Dublin, California, United States), Absorb LMS Software Inc. (Calgary, Alberta, Canada), Blackboard Inc. (Washington, D.C., United States), Cornerstone OnDemand, Inc. (Santa Monica, California, United States), Oracle Corporation (Redwood City, California, United States) Pune, India, June 11, 2021 (GLOBE NEWSWIRE) — The global learning management system market is set to gain momentum from the increasing usage of multiple channels platforms by the millennials. Hence, several organizations are developing multichannel and tech-dependent training facilities. This information is given by Fortune Business Insights™ in a new...

Continue reading

Electric Motor Market to Exhibit 7.0% CAGR by 2028 Backed by Increasing Demand for Electric Vehicles in Europe

Leading Companies in the global Electric Motor Market are ABB (Switzerland), AMETEK (United States), Johnson Electric (China), Siemens (Germany), Rockwell Automation (United States), GE (United States), Nidec Motor Corporation (Japan), WEG (Brazil), Toshiba Corporation (Japan), Hitachi (Japan), Mitsubishi Heavy Industries (Japan), TECO-Westinghouse Motor Company (United States), Arc Systems Inc. (Japan), DENSO (Japan), Regal Beloit Corporation (United States) Pune, India, June 11, 2021 (GLOBE NEWSWIRE) — The global electric motor market  size is expected to showcase considerable growth by reaching USD 181.89 billion by 2028 while exhibiting a CAGR of 7.0% between 2021 and 2028. Fortune Business Insights published this information in its latest report, titled, “Electric Motor Market, 2021-2028.” The report further mentions that...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.